Shares of Nuvilex Inc. (NASDAQ:PMCB – Get Free Report) were down 3.4% during trading on Thursday . The company traded as low as $1.10 and last traded at $1.10. Approximately 4,487 shares changed hands during trading, a decline of 77% from the average daily volume of 19,567 shares. The stock had previously closed at $1.14.
Nuvilex Stock Performance
The firm has a market capitalization of $7.55 million, a price-to-earnings ratio of 1.49 and a beta of -0.42. The business has a fifty day moving average price of $1.08 and a 200 day moving average price of $1.38.
About Nuvilex
PharmaCyte Biotech, Inc, a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer.
Read More
- Five stocks we like better than Nuvilex
- Breakout Stocks: What They Are and How to Identify Them
- Rigetti Computing: Cantor’s Bullish Call May Be Just the Start
- What Are Dividend Challengers?
- Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo Lead
- Consumer Staples Stocks, Explained
- 3 Top Stocks Under $20 Riding the “Made in America” Wave
Receive News & Ratings for Nuvilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvilex and related companies with MarketBeat.com's FREE daily email newsletter.
